It is consistent with the view that TIM-3 functions as a co-inhibitory immune checkpoint molecule in AML on NK cells, similar to the role of PD-1 and TIGIT in previous studies [51,52,53], and coincides with the reports of the role of TIM-3 expression on NK cells in other tumor types [54,55]. Here, TIGIT is linked to acute myeloid leukemia.